Rite Aid (RAD) Front-End Comps Down 1.7% in August
Tweet
Share
E-mailGet Alerts RAD Hot Sheet
Join SI Premium – FREE
Rite Aid Corporation (NYSE: RAD) announced sales results for August.
Monthly Sales
For the five weeks ended Aug. 31, 2013, same store sales increased 1.1 percent over the prior-year period. August front-end same store sales decreased 1.7 percent. Pharmacy same store sales, which included an approximate 161 basis points negative impact from new generic introductions, increased 2.5 percent. Prescription count at comparable stores decreased 0.2 percent over the prior-year period.
Total drugstore sales for the five-week period increased 1.1 percent to $2.425 billion compared to $2.399 billion for the same period last year. Prescription sales accounted for 68.4 percent of drugstore sales, and third party prescription sales represented 97.1 percent of pharmacy sales.
Quarterly Sales
Same store sales for the 13-week period ended Aug. 31, 2013 increased 1.0 percent over the prior-year period. Front-end same store sales decreased 0.3 percent while pharmacy same store sales increased 1.7 percent. Prescription count at comparable stores was flat compared to the prior-year period.
Total drugstore sales for the 13 weeks ended Aug. 31, 2013 increased 0.7 percent with sales of $6.250 billion compared to $6.205 billion for the same period last year. Prescription sales represented 67.9 percent of total drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Year-to-Date
Same store sales for the 26-week period ended Aug. 31, 2013 decreased 0.8 percent over the prior-year period. Front-end same store sales were flat compared to the prior-year period while pharmacy same store sales decreased 1.1 percent. Prescription count at comparable stores decreased 0.1 percent over the prior-year period.
Total drugstore sales for the 26 weeks ended Aug. 31, 2013 decreased 1.0 percent with sales of $12.514 billion compared to $12.646 billion for the same period last year. Prescription sales represented 67.7 percent of total drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Monthly Sales
For the five weeks ended Aug. 31, 2013, same store sales increased 1.1 percent over the prior-year period. August front-end same store sales decreased 1.7 percent. Pharmacy same store sales, which included an approximate 161 basis points negative impact from new generic introductions, increased 2.5 percent. Prescription count at comparable stores decreased 0.2 percent over the prior-year period.
Total drugstore sales for the five-week period increased 1.1 percent to $2.425 billion compared to $2.399 billion for the same period last year. Prescription sales accounted for 68.4 percent of drugstore sales, and third party prescription sales represented 97.1 percent of pharmacy sales.
Quarterly Sales
Same store sales for the 13-week period ended Aug. 31, 2013 increased 1.0 percent over the prior-year period. Front-end same store sales decreased 0.3 percent while pharmacy same store sales increased 1.7 percent. Prescription count at comparable stores was flat compared to the prior-year period.
Total drugstore sales for the 13 weeks ended Aug. 31, 2013 increased 0.7 percent with sales of $6.250 billion compared to $6.205 billion for the same period last year. Prescription sales represented 67.9 percent of total drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Year-to-Date
Same store sales for the 26-week period ended Aug. 31, 2013 decreased 0.8 percent over the prior-year period. Front-end same store sales were flat compared to the prior-year period while pharmacy same store sales decreased 1.1 percent. Prescription count at comparable stores decreased 0.1 percent over the prior-year period.
Total drugstore sales for the 26 weeks ended Aug. 31, 2013 decreased 1.0 percent with sales of $12.514 billion compared to $12.646 billion for the same period last year. Prescription sales represented 67.7 percent of total drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Radiopharm raises up to $13M via US and Australian offerings
- BayCom director resigns with no disagreement cited
- Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
